COVID-19: Up to 82% critically ill patients had low Vitamin C values
Tomasa-Irriguible TM, Bielsa-Berrocal L
Nutrition journal · 9 de julio de 2021
RESUMEN DE LOS AUTORES
There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.
Resumen original, reproducido sin modificaciones. © Los autores, distribuido con licencia Creative Commons CC BY. Las condiciones exactas figuran en el artículo original.
Contenido de información científica; no sustituye la opinión de un profesional sanitario. La presencia de un estudio en esta biblioteca no constituye una declaración sobre nuestros productos.
← Todos los estudios